Optimize therapeutic performance and increase patient acceptability with customized release technologies from Adare.
Adare’s customized delivery technologies optimize efficacy, safety, and dosing frequency and can be combined to create formulations exhibiting unique release profiles in a single dosage form.
Modified & Targeted Release
|
Key advantages
|
The following Adare technologies offer customized release capabilities:
 |
 |
 |
 |
 |
 |
For more information on these customized release technologies, review the Related Resources and speak with one of our experts today.
Speak With An Expert
Nathan Dormer
Director, Drug Product Development
Nathan Dormer, Ph.D., is the Director of Drug Product Development at Adare Pharma Solutions and is responsible for pharmaceutical development activities at Adare’s Lenexa, KS site where he supports a team of formulation scientists and analysts. He is a pharmaceutical scientist and bioengineer by training, with more than 16 years of experience developing microsphere-based solid oral and parenteral/implantable dosage forms in academic, innovator, and CDMO settings. Dr. Dormer earned his B.S. in Chemical Engineering and his Ph.D. (w/Honors) in Bioengineering from The University of Kansas while receiving NIH-sponsored Pharmaceutical Biotech Training.
